Isosceles Pharmaceuticals, Inc.
Isosceles Pharmaceuticals, Inc.
Business Address
1213 Culbreth Dr.
Suite 359
Primary Contact
Brett Lanier
Primary Phone
Long Business Description

Isosceles Pharmaceuticals is a preclinical stage pharmaceutical company, currently developing intravenous formulations of synthetic Cannabidiol, one of the many active chemicals in cannabis, as a non-addictive alternative to opium-derived painkillers – like oxycodone, hydrocodone, and fentanyl – for the treatment of postoperative acute pain. The company is also in development of an intradermal microneedle formulation for a “microneedle patch” to be used in pain management.